Answers are grounded in this paper and cite their sources.
This randomized trial analyzes cost and performance outcomes of ACOs with various specialist integrations, suggesting policy reforms are needed.
Evidence from the Medicare Shared Savings Program (MSSP) suggests that physician-led accountable care organizations (ACOs) outperform hospital-led ACOs—a distinction reflected in the Centers for Medicare & Medicaid’s (CMS) high-revenue and low-revenue ACO classifications. However, the role of hospital employment of specialists in shaping beneficiary attribution and observed ACO spending remains unexplored. Using Medicare 100% Innovator Research data (2022–2024), this study analyses populations across five ACO types: ACOs identified by a CMS Certification Number, High-Risk, High-Specialty, Medium-Specialty, and Low-Specialty. Results show that high-specialty ACOs are highly represented in CMS’ high-revenue designation (75%), while low-specialty ACOs are highly represented in CMS’ low-revenue designation (79%), suggesting that CMS revenue designations reflect differences in specialist participation as much as organizational performance. High-specialty ACOs have higher average per-beneficiary costs than low-specialty ACOs, but these costs are associated with substantially higher patient risk. Notably, concurrent risk adjustment more closely explains observed spending differences between low- and high-specialty ACOs than prospective HCC risk adjustment. With nearly half of Traditional Medicare beneficiaries not in value-based models, these findings underscore the need for policy reforms that more deliberately integrate specialists into ACOs.
No takes yet. Share an insight, caveat, or question.
McMullan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: